PremiumThe FlyTeladoc price target lowered to $12 from $14 at Canaccord Teladoc’s Growth Potential Bolstered by Strategic Acquisition and Strong Performance Teladoc Health: Hold Rating Amid Strategic Acquisition and Segment Uncertainties PremiumThe FlyTeladoc sees 2025 EPS ($1.40)-(90c), consensus ($1.03) Teladoc sees Q2 EPS (40c)-(20c), consensus (26c) Teladoc acquires UpLift Health for $30M in cash PremiumThe FlyUnusually active option classes on open April 29th Options Volatility and Implied Earnings Moves This Week, April 29 – May 02, 2025 Teladoc Inc. (TDOC) Q1 Earnings Cheat Sheet 
